Details for New Drug Application (NDA): 021123
✉ Email this page to a colleague
The generic ingredient in ULTRACET is acetaminophen; tramadol hydrochloride. There are sixty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the acetaminophen; tramadol hydrochloride profile page.
Summary for 021123
Tradename: | ULTRACET |
Applicant: | Janssen Pharms |
Ingredient: | acetaminophen; tramadol hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 325MG;37.5MG | ||||
Approval Date: | Aug 15, 2001 | TE: | RLD: | Yes |
Expired US Patents for NDA 021123
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharms | ULTRACET | acetaminophen; tramadol hydrochloride | TABLET;ORAL | 021123-001 | Aug 15, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | ULTRACET | acetaminophen; tramadol hydrochloride | TABLET;ORAL | 021123-001 | Aug 15, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription